Join me to discover how integrating mass photometry into antibody development workflows can drive rapid reliable decision-making.
Mass photometry enhances antibody development workflows with insights from:
- Column-free aggregation assessment in minutes using only nanograms of sample
- In solution assessment of antibody-antigen binding mechanisms from nM and uM concentration samples
- Streamlined methodology consisting of only one modality agnostic optimization step (for example, mAbs: IgG and IgM, and BsAbs)
